COMBINATIONS OF CONTRAST AGENTS

FAP INHIBITORS

METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY

1,4-BIS-(2-HYDROXY-BENZYL)-1,4,7-TRIAZACYCLONONANE DERIVATIVES AND SIMILAR COMPOUNDS AS LIGANDS IN IRON(III) COMPLEXES FOR USE AS MRI CONTRAST AGENTS

FAP INHIBITOR

COMPOSITION AND METHOD FOR DIAGNOSTIC IMAGING

GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING

ZWITTERIONIC METAL CHELATORS

GADOLINIUM-BASED COMPOUND, AND MRI CONTRAST AGENT INCLUDING SAME

TISSUE-SPECIFIC MANGANESE BASED MRI CONTRAST AGENTS

LANTHANIDE COMPLEX FORMULATIONS

GADOLINIUM BEARING PCTA-BASED CONTRAST AGENTS

LANTHANIDE COMPLEX FORMULATIONS

COMPLEX OF GADOLINIUM AND A CHELATING LIGAND DERIVED FROM A DIASTEREOISOMERICALLY ENRICHED PCTA AND PREPARATION AND PURIFICATION PROCESS

EXTRADOMAIN B FIBRONECTIN TARGETING PEPTIDES AND DERIVATIVES FOR CANCER IMAGING AND THERAPY

PROCESS FOR THE MANUFACTURING OF A GADOLINIUM COMPLEX SOLUTION

MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES

MANGANESE-ENHANCED MAGNETIC RESONANCE IMAGING

Manufacturing of dimeric contrast agents

IRON(III) MACROCYCLIC COMPLEXES WITH MIXED HYROXYL PENDANTS AS MRI CONTRAST AGENTS

Chiral TACN/NOTA compounds/derivatives with and without metals for application

REACTIVE CONJUGATES

FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING

COMPOUND AND MRI CONTRAST AGENT CONTAINING SAME

METHOD FOR MULTIMODAL TISSUE IMAGING BASED ON RESONANCE RAMAN EFFECT ON METAL BASED MRI CONTRAST AGENTS AND METHOD FOR IONIZING LASER PLUMES THROUGH ATMOSPHERIC PRESSURE CHEMICAL IONIZATION

Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents

HYPOXIA-TARGETING CONTRAST AGENT AND METHODS OF USE THEREOF

Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process

CAR Peptide for Improved Coronavirus Survival

NEW GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING

TEXAPHYRIN-PT(IV) CONJUGATES AND COMPOSITIONS FOR USE IN OVERCOMING PLATINUM RESISTANCE

FAP INHIBITOR

BIOGENIC HEMIN-BASED MRI CONTRAST AGENTS, AND COMPOSITIONS AND METHODS THEREOF

IGF-1R MONOCLONAL ANTIBODIES AND USES THEREOF

CROSS-LINKING COMPOUNDS AND METHODS OF USE THEREOF

COMPOSITIONS COMPRISING HYPERPOLARIZED PROBES FOR H2O2 SENSING AND METHODS OF USING SAME

Lanthanide complex formulations

IRON(III) COMPLEXES HAVING NEW CONTRAST AGENT PROPERTIES, FOR MAGNETIC RESONANCE IMAGING

COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS

NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME

NARROW EMISSION DYES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR MAKING AND USING SAME

Cyclen based compounds, coordination compounds, peptides, pharmaceutical preparation, and use thereof

SOLVENT FREE GADOLINIUM CONTRAST AGENTS

HEPARANASE COMPOUNDS AND METHODS OF USE

Indicator fluids, systems, and methods for assessing movement of substances within, to or from a cerebrospinal fluid, brain or spinal cord compartment of a cranio-spinal cavity of a human

METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY

Complex of gadolinium and a chelating ligand derived from a diastereoisomerically enriched PCTA and preparation and purification process

FORMATION AND USES OF EUROPIUM

Transition Metal Macrocyclics as MRI Contrast Agents for Molecular Imaging

FLUOROUS METAL CHELATES COMPOSITIONS

Complex of gadolinium and a chelating ligand derived of a diastereoisomerically enriched PCTA and synthesis method

Imaging Agents

Methods for Cell Labeling and Medical Imaging

In-case stand for a musical instrument

Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices

Method for preparing an Fe-tCDTA contrast agent and product obtainable by the method

Compounds for use as iron (III) MRI contrast agents containing anionic pendents and ancillary groups

HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING

Gadolinium bearing PCTA-based contrast agents

Targeting nanoparticles

Dual-targeted carbonic anhydrase ix complex and contrast agent thereof

Polarisation transfer via a second metal complex

Method for synthesizing silica nanoparticles

FAP INHIBITOR

Formulations and kits for radiotherapy and diagnostic imaging

Long-lived gadolinium based tumor targeted imaging and therapy agents

HYPERPOLARISATION IN AQUEOUS MEDIA VIA SABRE

Tailored dose of contrast agent

Gadolinium bearing PCTA-based contrast agents

Double-labeled probe for molecular imaging and use thereof

Gadolinium chelate compounds for use in magnetic resonance imaging

Anionic chelate compounds

METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY

COMPOSITION, COMPOSITION FOR DYNAMIC NUCLEAR POLARIZATION, POLARIZATION ENHANCING METHOD, HIGHLY POLARIZED SUBSTANCE, AND NMR MEASUREMENT METHOD

High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging

Lipophilic macrocyclic ligands, complexes thereof, and uses of same

Particles comprising bilirubin derivative and metal

Biogenic hemin-based MRI contrast agents, and compositions and methods thereof

Indicator fluids, systems, and methods for assessing movement of substances within, to or from a cerebrospinal fluid, brain or spinal cord compartment of a cranio-spinal cavity of a human

3,6,9, 15-tetraaza-bicyclo [9.3.1]pentadeca-1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based MRI and 52MN based PET contrast agents

Lanthanide complex formulations

RADIOACTIVE PROBE FOR DETECTING HYDROGEN SULFIDE

Mn(II)-based sensors to detect zinc in vivo with MRI

Compounds for use as iron(III) MRI contrast agents

Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance

Albumin-binding PSMA inhibitors

Formation and uses of europium

Solvent-free gadolinium contrast agents

MATERIALS AND METHODS FOR TREATING REGIONAL PAIN

Method for multimodal tissue imaging based on resonance Raman effect on metal based MRI contrast agents and method for ionizing laser plumes through atmospheric pressure chemical ionization

Metal complexes with bisphophonate or pyrophosphate useful as imaging agents

Tetrapyrroles conjugates as MRI contrast agent

CEST systems exhibiting a concentration independent responsiveness

Long-lived gadolinium based tumor targeting imaging and therapy agents

Contrast agents

Gadolinium-based contrast agents for sensitive detection of Znwith MRI

Manganese complexes with substituted bisphosphonates useful as imaging and therapeutic agents

Composition intended to vectorise an anti-cancer agent

IGF-1R monoclonal antibodies and uses thereof

Gadolinium chelate compounds for use in magnetic resonance imaging

PAMAM dendrimer based CEST imaging agents and uses thereof

Zinc sensors for in vivo imaging of beta-cell function by MRI

Method of diagnosing and/or monitoring therapy of atherosclerosis

Radioactive probe for detecting hydrogen sulfide

Hyperpolarized noble gas production systems with nanocluster suppression, detection and/or filtering and related methods and devices

6-oxa-3,9,15-triaza-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene derivatives based compounds and their application as ligands of essential metal ion based MRI and MN based PET contrast agents

Low molecular weight derivatives of carboxamide halogenated porphyrins, namely chlorins and bacteriochlorins, and their applications thereof

Nanoparticles

Gadolinium chelate compounds for use in magnetic resonance imaging

Magnetic nanoparticles for disease diagnostics

Preparation of high-purity gadobutrol

Crystalline contrast agent for magnetic resonance imaging, kit and composition comprising it and their use

Methods for cell labeling and medical imaging

Ethylenediaminetetraacetic acid bis(amide) derivatives and their respective complexes with Mn(II) ion for use as MRI contrast agent

System and method for enhanced mass spectrometry imaging

Method for preparing gadobutrol

Targeting corroles for tumor toxicity and MRI

Metal complex formulations

Lanthanide complex formulations

Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance

Process for preparing a pharmaceutical formulation of contrast agents

Metal complexes with bisphosphonate useful as imaging agents

Modified biotin, streptavidin mutant, and usage of them

Long-lived gadolinium based tumor targeted imaging and therapy agents

Gadolinium-based contrast agents for sensitive detection of Znwith MRI

Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy

Molecular Imaging Probes

N-alkoxyamide conjugates as imaging agents

HBED-bisphosphonates, radiometal conjugates and their use as theranostic agents

Methods and compounds for enhancing contrast in magnetic resonance imaging (MRI)

Gadolinium complex comprising DO3A-tranexamic acid conjugate

CATIONIC CONTRAST AGENTS AND METHODS OF USING THE SAME

In vivo differentiation of relative oxygen levels and tumor necrosis using divalent europium

Imaging beta-amyloid peptides aggregation

Process for preparing a pharmaceutical formulation of contrast agents

MRI CONTRAST AGENTS FOR CELL LABELING

Macrocycles, cobalt and iron complexes of same, and methods of making and using same

Synthesis of imidazo[1,2-a]pyrazin-4-ium salts for the synthesis of 1,4,7-triazacyclononane (tacn) and N- and/or C- functionalized derivatives thereof

Iron-salen complex

N-alkoxyamide conjugates as imaging agents

GRP-R agonistic 177-lutetium-labeled bombesin derivatives for diagnosis and treatment of prostate cancer

Contrast medium formulation and related preparation method

Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using

Process for manufacture of gadofosveset trisodium monohydrate

LANTHANIDE CLUSTERS AND METHODS OF USE THEREOF

Pharmaceutical compounds targeted by MIF affinity-tethered moieties

Manganese-based magnetic resonance contrast agents

Contrast reagent leakage correction in dynamic susceptibility contrast magnetic resonance imaging

Dual mode gadolinium nanoparticle contrast agents

Paramagnetic solid lipid nanoparticles (pSLNs) containing metal amphiphilic complexes for MRI

Contrast Agent and Applications Thereof

Sulfonic esters of metal oxides and methods of their use

Contrast agent for nuclear magnetic resonance imaging comprising melanin nanoparticles stably dispersed in water

N-alkoxyamide conjugates as imaging agents

Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof

Dynamic contrast enhanced MRI method and agents for the assessment of the macromolecular transport within pathologic tissues

Class of diazepine derivative chelating agents and complexes with paramagnetic metals thereof as MRI contrast agents

Composition comprising acetic anhydride and a gadolinium complex, and method for the use in hyperpolarisation in MRI analysis

Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma

Targeting corroles for tumor toxicity and MRI

Aza metal complexes

Bacteria-targeted magnetic resonance contrast agents

Porphyrin compounds and their use as MRI contrast agents

Imaging contrast agents and uses thereof

Multimeric biotinidase resistant multimodality probes

Synthesis of imidazo[1,2-a]pyrazin-4-ium salts for the synthesis of 1,4,7-triazacyclononane (tacn) and N- and/or C-functionalized derivatives thereof

Lipidomimetic compounds and uses thereof

Preparation of high-purity gadobutrol

Pretargeting kit for imaging or therapy comprising a trans-cyclooctene dienophile and a diene

Fe(II) sequestering agents and uses thereof

Multimeric peptidomimetic fibrosis specific dual-modality probes

Fibrosis specific multimeric peptidomimetic radiotracers

PROCESS FOR PREPARING A PHARMACEUTICAL FORMULATION OF CONTRAST AGENTS

N-alkoxyamide conjugates as imaging agents

MRI contrast agent having gadolinium complex

Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma

CEST systems exhibiting a concentration independent responsiveness

Lipid bilayer carrier for drugs or imaging agents

Compositions and methods for treating nephropathy

Compositions and methods comprising magnetic resonance contrast agents

Carbonylporphyrins and uses thereof

Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof

Manganese chelates and their use as contrast agents in magnetic resonance imaging (MRI)

VITAL FLUOROCHROME CONJUGATES AND METHODS OF USE

Diagnostic imaging contrast agents with extended blood retention

Complex compound and MRI probe made of same

Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma

METAL RESPONSIVE MRI-AGENTS

Complex Compound and MRI Probe Made of Same

Process for preparing a pharmaceutical formulation of contrast agents

Diagnostic agents selective against metalloproteases

Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules

Removal of silica from water soluble compounds by nanofiltration and reverse phase chromatography

MR IMAGING AGENT, IMAGING MEDIUM AND METHODS OF IMAGING WHEREIN SUCH AN IMAGING MEDIUM IS USED

METHOD OF DETERMINATION OF PDH ACTIVITY AND IMAGING MEDIA FOR USE IN SAID METHOD

AZA compounds and production method thereof, and metal complexes as MRI contrast agents

FLUORINATED LANTHANIDE PROBES FOR 19F MAGNETIC RESONANCE APPLICATIONS

Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using

Preparation for restenosis prevention

Preparation for restenosis prevention

Magnetic resonance imaging contrast agent with paramagnetic-inositol phosphates complexes

Method of dynamic nuclear polarisation (DNP) and compounds and compositions for use in the method

MULTIMODAL IMAGING PROBES FOR IN VIVO TARGETED AND NON-TARGETED IMAGING AND THERAPEUTICS

Hyperpolarized 89-yttrium and methods relating thereto

Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy

Perfluoroalkyl-Containing Complexes, Process For Their Production As Well As Their Use

N-alkoxyamide conjugates as imaging agents

Responsive paramagnetic MRI contrast agents

Lipophilic chelates and their use in imaging

In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging

Process for preparing a pharmaceutical formulation of contrast agents

IRON-SALEN COMPLEX

Compounds comprising short aminoalcohol chains and metal complexes for medical imaging

Activatable cest MRI agent

Paramagnetic Complexes with Pendant Crown Compounds Showing Improved Targeting- Specificity as MRI Contrast Agents

BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS

PHTHALAMIDE-LANTHANIDE COMPLEXES FOR USE AS LUMINESCENT MARKERS

Polybiotin compounds of magnetic resonance imaging and drug delivery

Method to produce hyperpolarised carboxylates

Glycosylated Carboranylporphyrins and Uses Thereof

MULTI-USE MULTIMODAL IMAGING CHELATES

Multi-use multimodal imaging chelates

Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof

Sensors for fluorescence and magnetic resonance imaging

Carboranylporphyrins and uses thereof

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

Method of Enhancing Visualization of Atherosclerotic Plaque

Use of perfluoroalkyl-containing metal complexes as contrast media for diagnosis of Alzheimer's disease

Optically pure and enriched isomers of chelating ligands and contrast agents

Targeted MR imaging agents

Contrast agents for magnetic resonance imaging

Polyamine-substituted ligands for use as contrast agents

Perfluoroalkyl-containing complexes, process for their production as well as their use

Optimized relaxivity and specificity hepatobiliary MRI contrast agent

Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma

Diagnostic imaging contrast agents with extended blood retention

Diagnostic imaging contrast agents with extended blood retention

Perfluoroalkyl-containing complexes, process for their production as well as their use

Diagnostic imaging contrast agents with extended blood retention

Chemical exchange saturation transfer contrast agents

Bioactivated diagnostic imaging contrast agents

Pharmaceutical agents that contain fluoroalkyl-containing metal complexes and epothilones

Optically pure and enriched isomers of chelating ligands and contrast agents

Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives

1,4,7,10-Tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them

Paramagnetic complexes with pendant crown compounds showing improved targeting-specificity as MRI contrast agents

Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy

Carboranylporphyrins and uses thereof

Preparation for the prophylaxis of restenosis

Biochemically-activated contrast agents for magnetic resonance imaging

Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis

Responsive paramagnetic MRI contrast agents

Polybiotin compounds for magnetic resonance imaging and drug delivery

Contrast-enhanced diagnostic imaging method for monitoring interventional therapies

Preparation for the prophylaxis of restenosis

Phthalamide-lanthanide complexes for use as luminescent markers

Magnetic resonance imaging agents for the detection of physiological agents